. . . . . . . . . . . "a(CHEBI:lovastatin) -> p(EGID:5243)" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "Here we show that lovastatin renders cells highly resistant to the tumor-therapeutic compound doxorubicin. Furthermore, lovastatin protects cells from doxorubicin-induced DNA strand breakage without affecting drug uptake or the expression of multidrug resistance protein (mdr-1)." . . "Selventa" . . . . "2014-07-03T14:30:05.989+02:00"^^ . . .